Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

The symptoms described align more with Haberland syndrome, not Delleman-Oorthuys syndrome.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

No treatment fully stops excessive hair growth in women, but various methods can help manage it effectively.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.